The Journal of Urology
Volume 170, Issue 1 , Pages 159-163 , July 2003

Comparison of Satisfaction Rates and Erectile Function in Patients Treated with Sildenafil, Intracavernous Prostaglandin E1 and Penile Implant Surgery for Erectile Dysfunction in Urology Practice

  • ATUL RAJPURKAR
    • ,
  • CHIRPRIYA B. DHABUWALA

      Affiliations

    • Corresponding Author InformationCorresponding author: Department of Urology, Suite 1017, 4160 John R., Detroit, Michigan 48201.
    • Financial interest and/or other relationship with Mentor Corp., American Medical Systems and Pfizer.

,Accepted 3 January 2003.

REFERENCES 

  1. Feldman HA , Goldstein I , Hatzichristou DG , Krane RJ , McKinlay JB . Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study . J Urol . 1994;151:54
  2. Johannes CB , Araujo AB , Feldman HA , Derby CA , Kleinman KP , McKinlay JB . Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study . J Urol . 2000;163:460
  3. Shabsigh R . Socioeconomic considerations in erectile dysfunction treatment . Urol Clin North Am . 2001;28:417
  4. Goldstein I , Lue TF , Padma-Nathan H , Rosen RC , Steers WD , Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group . N Engl J Med . 1998;338:1397
  5. Montorsi F , McDermott TE , Morgan R , Olsson A , Schultz A , Kirkeby HJ , et al.   Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies . Urology . 1999;53:1011
  6. McMahan CG , Samali R , Johnson H . Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction . J Urol . 2000;164:1192
  7. Hatzichristou DG . Sildenafil citrate: lessons learned from 3 years of clinical experience . Int J Impot Res . 2002;14:S43
  8. Porst H . The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience . J Urol . 1996;155:802
  9. Linet OI , Ogrinc FG . Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group . N Engl J Med . 1996;334:873
  10. Willke RJ , Glich HA , McCarron TJ , Erder MH , Althof SE , Linet OI . Quality of life effects of alprostadil therapy for erectile dysfunction . J Urol . 1997;157:2124
  11. Gupta R , Kirschen J , Barrow RC , II and Eid JF . Predictors of success and risk factors for attrition in the use of intracavernous injection . J Urol . 1997;157:1681
  12. Irwin MB , Kata EJ . High attrition rate with intracavernous prostaglandin E1 for impotency . Urology . 1994;43:84
  13. Carson CC , Mulcahy JJ , Govier FE  AMS 700CX Study Group . Efficacy, safety and patient satisfaction outcomes of the AMS 700 CX inflatable penile prosthesis: results of a long-term multicenter study . J Urol . 2000;164:376
  14. Wilson SK , Cleves MA , Delk JR . Comparison of mechanical reliability of original and enhanced Mentor Alpha 1 penile prosthesis . J Urol . 1999;162:715
  15. Sexton WJ , Benedict JF , Jarow JP . Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy . J Urol . 1998;159:811
  16. Altof SE , Corty EW , Levine SB , Levine F , Burnett AL , McVary K , et al.   EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction . Urology . 1999;53:793
  17. Rosen RC , Riley A , Wagner G , Osterloh IH , Kirkpatrick J , Mishra A . The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction . Urology . 1997;49:822
  18. McLaren RH , Barrett DM . Patient and partner satisfaction with the AMS 700 penile prosthesis . J Urol . 1992;147:62
  19. Whalen RK , Merrill DC . Patient satisfaction with Mentor inflatable penile prosthesis . Urology . 1991;37:531
  20. Giuliano F , Montorsi F , Mirone V , Rossi D , Sweeney M  The Sildenafil Multicenter Study Group . Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study . J Urol . 2000;164:708
  21. Hatzichristou DG . Current treatment and future perspectives for erectile dysfunction . Int J Impot Res, suppl . 1998;10:S3
  22. Hatzichristou DG , Apostolidis A , Tzortzis V , Ioannides E , Yannakoyovgos K , Kalinderis A . Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year . J Urol . 2000;164:1197
  23. Jarow JP , Burnett AL , Geringer AM . Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment . J Urol . 1999;162:722

PII: S0022-5347(05)63458-1

doi: 10.1097/01.ju.0000072524.82345.6d

The Journal of Urology
Volume 170, Issue 1 , Pages 159-163 , July 2003

Article Tools

* Image Usage & Resolution